These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon alpha-2a and ribavirin. Yu JW, Wang GQ, Sun LJ, Li XG, Li SC. J Gastroenterol Hepatol; 2007 Jun; 22(6):832-6. PubMed ID: 17565637 [Abstract] [Full Text] [Related]
4. The comparison of the efficacy of pegylated interferon α-2a and α-2b in chronic hepatitis C patients with genotype 1. Dogan UB, Atabay A, Akin MS, Yalaki S. Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1082-5. PubMed ID: 23524524 [Abstract] [Full Text] [Related]
9. Virological response at 4 weeks to predict outcome of hepatitis C treatment with pegylated interferon and ribavirin. Martinot-Peignoux M, Maylin S, Moucari R, Ripault MP, Boyer N, Cardoso AC, Giuily N, Castelnau C, Pouteau M, Stern C, Aupérin A, Bedossa P, Asselah T, Marcellin P. Antivir Ther; 2009 Sep; 14(4):501-11. PubMed ID: 19578235 [Abstract] [Full Text] [Related]
10. A preliminary study on the efficacy and influencing factors of interferon for the treatment of genotype 1 chronic hepatitis C with different dosage forms. Ma P, Yang JM, Hou W, Song SD, Wang L, Lu W. Eur J Gastroenterol Hepatol; 2013 May; 25(5):601-5. PubMed ID: 23263720 [Abstract] [Full Text] [Related]
16. Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C. Martin-Carbonero L, Nuñez M, Mariño A, Alcocer F, Bonet L, García-Samaniego J, López-Serrano P, Cordero M, Portu J, Soriano V. AIDS; 2008 Jan 02; 22(1):15-21. PubMed ID: 18090387 [Abstract] [Full Text] [Related]